Abstract:Kamrin Kamalpersad, Giuseppe Luna, Bruce Sunderland, Petra Czarniak Discipline of Pharmacy, Curtin Medical School, Faculty of Health Sciences, Curtin University, Bentley, Western Australia, Australia Correspondence: Petra Czarniak, Discipline of Pharmacy, Curtin Medical School, Faculty of Health Sciences, Curtin University, Kent Street, Bentley, Western Australia, 6102, Australia, Tel +61 89266 7419, Email Purpose: Amoxicillin/clavulanate antibiotic combination is suitable for treating a range of infections, including some suited for Outpatient Parenteral Antimicrobial Therapy (OPAT). The aim of the study was to evaluate shelf-life values of amoxicillin at clinical concentrations in the presence of clavulanate for use in OPAT. Methods: A stability-indicating HPLC assay was developed and validated. Kinetic studies were performed at 1 mg/mL and 15 mg/mL amoxicillin at 40– 60 °C. Studies in elastomeric infusers included the pH lowered from 8.73 to 6.52 for 1 mg/mL; 8.85 to 7.69 for 7.5 mg/mL and 8.68 to 8.40 for 15 mg/mL amoxicillin plus clavulanate and stored at 2.9 °C. Results: Amoxicillin and clavulanate eluted at 5.2 and 3.0 minutes, respectively, with linear concentration relationships. Forced degradation retained base-line separation of each component in the presence of degradation products. Amoxicillin 1 mg/mL had a shelf-life of 4.85 hours at pH 6.53 and 40 °C which on extrapolation to 25 °C was 22.8 h. Clavulanate was 1.38 h at 40 °C and 4.0 h at 25 °C. Amoxicillin 15 mg/mL at pH 8.34 gave a shelf-life of 0.11 h at 40 °C and clavulanate 0.41 h. In elastomeric infusers, amoxicillin 1 mg/mL, with lowering pH from 8.73 to 6.52, improved the shelf-life at 2.9 °C from 72 to > 263.8 h and similarly for clavulanate. At 7.5 mg/mL amoxicillin, lowering pH from 8.85 to 7.69 improved the shelf-life from 4.2 to 51.8 h and clavulanate from 4.2 to 48.0 h. At 15 mg/mL amoxicillin, the shelf-life values at pH 8.68 or 8.40 were 3.8 h and 1.6 h and similarly for clavulanate. Conclusion: Amoxicillin and clavulanate showed adequate stability at 2.9 °C for OPAT storage at 1 mg/mL and possibly 7.5 mg/mL, but not 15 mg/mL. Low shelf-life values at 25 °C also limit administration times. Keywords: amoxicillin, clavulanate, stability, shelf-life, OPAT, infusers Amoxicillin is a moderate spectrum penicillin with greater antimicrobial activity than narrow spectrum penicillins against selected Gram-negative bacteria such as Escherichia coli and Haemophilus influenzae . 1 It is commonly prescribed for respiratory infections including bronchitis, community-acquired pneumonia, urinary tract infections, acute prostatitis and for endocarditis prophylaxis in high-risk patients. 2 Amoxicillin is inactivated by bacterial strains that produce beta-lactamase enzymes, which hydrolyse the beta-lactam ring, rendering amoxicillin inactive. The combination of amoxicillin with clavulanate, a beta-lactamase inhibitor with little innate antibacterial activity, broadens the spectrum of its activity to include Staphylococcus aureus and Bacteroides fragilis . 3 In addition, it provides activity against some beta-lactamase enzymes produced by Escherichia coli and Klebsiella species. 2,3 Amoxicillin is a time-dependent antibiotic and its efficacy during the dosing interval is dependent on the time the free-serum concentration is maintained above the minimum inhibitory concentration (MIC). 1 Concentrations can be maintained above the MIC for longer periods of time when administered by continuous infusion. 4 The stability of amoxicillin has been examined in a range of kinetic and clinical studies. It is an amphoteric substance with the protonated amino species (pKa 2.63) powerfully attracting electrons providing higher acidic stability than penicillin G. 5 At low concentrations, amoxicillin undergoes hydrolytic degradation exhibiting pseudo first-order kinetics over the pH range 1 −10 with a pH minimum value at pH 6, with little change in reaction rates between pH 5–7. The deprotonated carboxylic acid form exists primarily above pH range 7 (pKa 7.16) and the deprotonation of the phenolic moiety (pKa 9.55) has little underlying effect on beta-lactam ring cleavage. 5–8 Both citrate and phosphate buffers have marked catalytic effects. 6 Amoxicillin also undergoes an autocatalytic reaction (self-ammonolysis) through a nucleophilic attack of the amino group on its side chain on the β-lactam ring leading to dimerization and subsequent polymerisation. 8 The rate of this reaction is dependent on the initial concentration of amoxicillin and becomes clinically important when high initial concentrations of amoxicillin are prepared. It -Abstract Truncated-

Stability Studies of Antipseudomonal Beta Lactam Agents for Outpatient Therapy

Ampicillin and Ceftriaxone Solution Stability at Different Temperatures in Outpatient Parenteral Antimicrobial Therapy

Enhancing Stability and Investigating Target Attainment of Benzylpenicillin in Outpatient Parenteral Antimicrobial Therapy: Insights from In Vitro and In Vivo Evaluations

Stability of meropenem in portable elastomeric infusion devices: which protocol should be implemented in clinical practice?

Quantification of Cefepime, Meropenem, Piperacillin, and Tazobactam in Human Plasma Using a Sensitive and Robust Liquid Chromatography-Tandem Mass Spectrometry Method, Part 2: Stability Evaluation

Comprehensive stability analysis of 13 β-lactams and β-lactamase inhibitors in in vitro media, and novel supplement dosing strategy to mitigate thermal drug degradation

Preanalytical Stability of 13 Antibiotics in Biological Samples: A Crucial Factor for Therapeutic Drug Monitoring

Systematic review of room temperature stability of key beta-lactam antibiotics for extended infusions in inpatient settings

From Bed to Bench: Pre-analytical Stability of 29 Anti-infective Agents in Plasma and Whole Blood to Improve Accuracy of Therapeutic Drug Monitoring

Outpatient parenteral antimicrobial therapy with carbapenems: A systematic review

A review of evidence, antimicrobial stability, and feasibility considerations for OPAT continuous infusion

Prolonged outpatient parenteral antimicrobial treatment: frequency and evolution over a six-year period in a Swiss University Hospital

Impact of chromosomally encoded resistance mechanisms and transferable β-lactamases on the activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against Pseudomonas aeruginosa

In vitro development of resistance against antipseudomonal agents: comparison of novel β-lactam/β-lactamase inhibitor combinations and other β-lactam agents

An Evaluation of Amoxicillin/Clavulanate Stability in Aqueous Systems, Including Its Suitability for Outpatient Parenteral Antimicrobial Therapy (OPAT)

[Outpatient parenteral antimicrobial therapy (OPAT) in bone and joint infections]

Optimizing Antibiotic Therapy for Stenotrophomonas maltophilia Infections in Critically Ill Patients: A Pharmacokinetic/Pharmacodynamic Approach

Short-term Outpatient Parenteral Antimicrobial Therapy Administration in the Pediatric Emergency Department: Feasibility, Safety, and Outcome

Stability Studies of the Dilution Series of Different Antibiotic Stock Solutions in Culture Medium Incubated at 37 °C

Current practices and challenges of outpatient parenteral antimicrobial therapy: a narrative review

Barriers and facilitators for the implementation and expansion of outpatient parenteral antimicrobial therapy: Systematic review